安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Oral therapy NUZ-001 cleared by FDA to join platform trial for ALS
NUZ-001, an investigational oral therapy being developed by Neurizon Therapeutics for the treatment of amyotrophic lateral sclerosis (ALS), is officially the ninth compound to be included in the HEALEY ALS platform trial
- Neurizon Therapeutics
After years of research and development, we are pioneering novel applications for NUZ-001 (S-Monepantel) Our initial focus is on Amyotrophic Lateral Sclerosis (ALS), the most common form of Motor Neurone Disease (MND)
- NUZ-001 arm in HEALEY ALS trial expands to 240 participants
The NUZ-001 arm of the HEALEY ALS trial is expanding enrollment to 240 participants NUZ-001 is an experimental ALS therapy designed to target the mTOR pathway and reduce toxic protein buildup Neurizon says the expansion may strengthen data analyses and support earlier top-line results
- In Santa Cruz Nuz, Is Hyundai Calling It Quits? - Hagerty
In Santa Cruz Nuz, Is Hyundai Calling It Quits? Stefan Lombard 30 January 2026 DREW PHILLIPS
- HEALEY ALS Platform Trial - Regimen I NUZ-001
Once Regimen I eligibility criteria are confirmed, participants will complete a baseline assessment and be randomized in a 3:1 ratio to either active NUZ-001 or matching placebo
- FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease
- Sean M. Healey AMG Center for ALS Announces First Participant . . .
The trial will evaluate NUZ-001, an oral therapy that targets key pathological mechanisms in ALS, including TDP-43 protein aggregation and impaired autophagy, which are central features across multiple neurodegenerative diseases
- FDA Lifts Clinical Hold on NUZ-001 - PR Newswire
Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease
|
|
|